← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Investors Title Company (ITIC) 10-Year Financial Performance & Capital Metrics

ITIC • • Insurance & Managed Care
Financial ServicesSpecialty InsuranceTitle InsuranceTitle Insurance Underwriters
AboutInvestors Title Company, through its subsidiaries, engages in the issuance of residential and commercial title insurance for residential, institutional, commercial, and industrial properties. The company underwrites land title insurance for owners and mortgagees as a primary insurer; and assumes the reinsurance of title insurance risks from other title insurance companies. It also provides services in connection with tax-deferred exchanges of like-kind property; acts as a qualified intermediary in tax-deferred exchanges of property; coordinates the exchange aspects of the real estate transaction, such as drafting standard exchange documents, holding the exchange funds between the sale of the old property and the purchase of the new property, and accepting the formal identification of the replacement property. In addition, it serves as an exchange accommodation titleholder for accomplishing reverse exchanges when the taxpayers decide to acquire replacement property before selling the relinquished property. Further, the company offers investment management and trust services to individuals, companies, banks, and trusts; and consulting and management services to clients to start and operate a title insurance agency. It issues title insurance policies primarily through approved attorneys from underwriting offices, as well as through independent issuing agents in 24 states and the District of Columbia, primarily in the eastern half of the United States. The company was founded in 1972 and is headquartered in Chapel Hill, North Carolina.Show more
  • Revenue $258M +14.9%
  • Combined Ratio 84.72% -4.1%
  • Net Income $31M +43.3%
  • Return on Equity 12.35% +40.2%
  • Medical Cost Ratio 43.31% +10.4%
  • Operating Margin 15.28% +30.9%
  • Net Margin 12.03% +24.7%
  • ROA 9.36% +44.6%
  • Equity / Assets 75.48% -0.8%
  • Book Value per Share 133.07 +0.1%
  • Tangible BV/Share 125.11 +0.6%
  • Debt/Equity 0.03 -1.5%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Profitable underwriting: 84.7% combined ratio
  • ✓Low loss ratio of 43.3%

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y7.69%
5Y7.08%
3Y-7.79%
TTM-16.79%

Profit (Net Income) CAGR

10Y12.38%
5Y-0.25%
3Y-22.6%
TTM-16.59%

EPS CAGR

10Y13.23%
5Y-0.21%
3Y-22.5%
TTM25.81%

ROCE

10Y Avg16.64%
5Y Avg14.9%
3Y Avg9.56%
Latest11.88%

Peer Comparison

Title Insurance Underwriters
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
FAFFirst American Financial Corporation6.17B60.5748.072.04%6.81%9.06%11%0.49
ITICInvestors Title Company481.71M255.2015.5414.93%11.86%8.56%4.65%0.03
FNFFidelity National Financial, Inc.14.31B52.7311.3415.92%8.52%12.52%46.61%0.55

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Revenue+127.2M138.49M161.63M156.26M183.5M236.41M329.5M283.39M224.75M258.3M
Revenue Growth %0.03%0.09%0.17%-0.03%0.17%0.29%0.39%-0.14%-0.21%0.15%
Medical Costs & Claims+66.65M63.89M71.95M65.44M76.31M112.01M148.5M125.82M88.14M111.87M
Medical Cost Ratio %----------
Gross Profit+60.55M74.6M89.67M90.82M107.19M124.4M181M157.57M136.61M146.43M
Gross Margin %----------
Gross Profit Growth %0.16%0.23%0.2%0.01%0.18%0.16%0.45%-0.13%-0.13%0.07%
Operating Expenses+42.77M46.47M59.4M63.75M67.37M74.74M96.06M127.46M110.38M106.96M
OpEx / Revenue %----------
Depreciation & Amortization1.11M1.52M2.35M2.23M2.26M2.26M2.44M3.58M4.12M4.5M
Combined Ratio %----------
Operating Income+17.78M28.13M30.27M27.07M39.82M49.66M84.93M30.11M26.23M39.46M
Operating Margin %----------
Operating Income Growth %0.32%0.58%0.08%-0.11%0.47%0.25%0.71%-0.65%-0.13%0.5%
EBITDA+18.88M29.65M32.62M29.3M42.09M51.92M87.37M33.69M30.35M43.96M
EBITDA Margin %----------
Interest Expense0000000000
Non-Operating Income0000000000
Pretax Income+17.78M28.13M30.27M27.07M39.82M49.66M84.93M30.11M26.23M39.46M
Pretax Margin %----------
Income Tax+5.23M8.62M4.57M5.21M8.37M10.24M17.91M6.21M4.54M8.39M
Effective Tax Rate %----------
Net Income+12.55M19.52M25.7M21.86M31.46M39.42M67.02M23.9M21.69M31.07M
Net Margin %----------
Net Income Growth %0.3%0.56%0.32%-0.15%0.44%0.25%0.7%-0.64%-0.09%0.43%
EPS (Diluted)+6.3010.1913.5611.5216.5920.7935.2712.5911.4616.42
EPS Growth %0.33%0.62%0.33%-0.15%0.44%0.25%0.7%-0.64%-0.09%0.43%
EPS (Basic)6.3210.2313.6311.5816.6620.8435.3912.6011.4616.48
Diluted Shares Outstanding1.99M1.92M1.9M1.9M1.9M1.9M1.9M1.9M1.89M1.89M

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Assets+211.52M228.94M248.91M244.27M263.89M282.93M331.49M339.76M330.56M333.57M
Asset Growth %0.07%0.08%0.09%-0.02%0.08%0.07%0.17%0.02%-0.03%0.01%
Total Investment Assets+160.55M258.17M301.61M182.67M192.86M213.29M222.87M227.7M228.67M232.54M
Long-Term Investments150.45M149.67M174.49M170.23M178.88M197.8M202.57M209.33M211.28M211.97M
Short-Term Investments112.93M108.49M127.12M121.74M117.77M132.88M125.72M157.64M174.07M172.07M
Total Current Assets+59.3B69.11B67.97B153.51M000000
Cash & Equivalents21.79M27.93M20.21M18.69M25.95M13.72M37.17M35.31M24.03M24.65M
Receivables001000K01000K1000K1000K1000K1000K1000K
Other Current Assets0000-162.8M-176.49M-198.38M-225.14M-227.02M-221.28M
Goodwill & Intangibles+1.22M12.26M11.36M10.78M10.28M9.77M15.95M17.61M16.25M15.07M
Goodwill04.35M4.35M4.35M4.35M4.35M7.2M9.63M9.63M9.63M
Intangible Assets1.22M7.91M7.01M6.43M5.93M5.42M8.75M7.99M6.62M5.45M
PP&E (Net)7.15M8.75M10.17M10.3M14.24M14.69M18.23M24.49M30.19M34.09M
Other Assets-158.81M12.09B11.16B-4.18M-203.4M-222.27M-236.76M-251.43M-257.72M-261.13M
Total Liabilities68.74M73.8M70.99M68.63M72.53M82.5M102.4M98.75M79.01M81.8M
Total Debt+00004.5M3.67M5.33M6.84M6.45M6.36M
Net Debt-21.79M-27.93M-20.21M-18.69M-21.45M-10.05M-31.84M-28.47M-17.58M-18.3M
Long-Term Debt0000000000
Short-Term Debt0000000000
Total Current Liabilities+210.35M1.23B27.57M27.73M000000
Accounts Payable25.04M26.15M27.57M27.73M28.32M36.02M43.87M47.05M31.86M34.01M
Deferred Revenue0000000000
Other Current Liabilities-33.07M-35.87M-27.57M-32.72M-29.66M-36.66M-47.2M-47.05M-31.86M-34.29M
Deferred Taxes1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Liabilities68.74M73.8M62.37M63.65M-11.54M-12.26M-18.45M-14.5M-9.99M-10.45M
Total Equity+142.78M155.14M177.92M175.64M191.36M200.42M229.09M241.01M251.55M251.77M
Equity Growth %0.04%0.09%0.15%-0.01%0.09%0.05%0.14%0.05%0.04%0%
Shareholders Equity142.67M155.05M177.84M175.64M191.36M200.42M229.09M241.01M251.55M251.77M
Minority Interest107.2K90.89K84.95K0000000
Retained Earnings131.19M143.28M161.89M174.69M188.26M196.1M225.86M240.81M250.91M251.42M
Common Stock0000000000
Accumulated OCI11.48M11.76M15.94M949K3.1M4.33M3.23M200K638K355K
Return on Equity (ROE)0.09%0.13%0.15%0.12%0.17%0.2%0.31%0.1%0.09%0.12%
Return on Assets (ROA)0.06%0.09%0.11%0.09%0.12%0.14%0.22%0.07%0.06%0.09%
Equity / Assets----------
Debt / Equity----0.02x0.02x0.02x0.03x0.03x0.03x
Book Value per Share71.7581.0193.8492.59100.93105.71120.57126.98132.89133.07
Tangible BV per Share----------

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+16.89M22.53M19.89M24.39M20.92M34.09M51.93M36.2M7.43M29.84M
Operating CF Growth %0.74%0.33%-0.12%0.23%-0.14%0.63%0.52%-0.3%-0.79%3.02%
Operating CF / Revenue %----------
Net Income12.55M19.52M25.7M21.86M31.46M39.42M67.02M23.9M21.69M31.07M
Depreciation & Amortization1.83M1.52M2.35M2.23M2.26M2.26M2.44M3.58M4.12M131K
Stock-Based Compensation137.76K132.1K219.31K327K264K229K299K362K425K393K
Deferred Taxes1.01M2.79M-4.66M-4.07M2.28M1.22M4.83M-4.64M-4.23M515K
Other Non-Cash Items-792.08K-4.23M-2.44M15K-13.58M-5.02M-20.64M9.65M-5.79M-5.75M
Working Capital Changes2.15M2.81M-1.27M4.03M-1.77M-4.01M-2.01M3.35M-8.78M3.48M
Cash from Investing+-4.7M-8.84M-20.29M-2.81M4.49M-14.6M9.07M-28.75M-6.7M1.75M
Capital Expenditures-2.74M-2.46M-2.88M-1.86M-1.49M-3.2M-6.53M-5.68M-9.19M-7.42M
Acquisitions-72.6K-8.33M-175K59K301K85K0-4.93M00
Purchase of Investments-28.48M-23.94M-51.35M-110.28M-133.82M-51.73M-45.32M-119.85M-210.06M-199.36M
Sale/Maturity of Investments1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Investing224.19K109.26K72.74K7K3K22K7.7M55K529K275K
Cash from Financing+-6.23M-7.56M-7.32M-23.1M-18.15M-31.72M-37.55M-9.31M-12.01M-30.96M
Dividends Paid-789.91K-1.37M-7.07M-23.02M-18.13M-31.72M-37.55M-9.18M-11.05M-29.86M
Share Repurchases-5.48M-6.22M-246K-29K-19K-6K0-133K-959K-1.1M
Stock Issued0000000000
Debt Issuance (Net)0000000000
Other Financing46.86K2600-53K01K-1K-1K00
Net Change in Cash+5.96M6.14M-7.71M-1.52M7.25M-12.23M23.45M-1.86M-11.28M623K
Exchange Rate Effect0000000000
Cash at Beginning15.83M21.79M27.93M20.21M18.69M25.95M13.72M37.17M35.31M24.03M
Cash at End21.79M27.93M20.21M18.69M25.95M13.72M37.17M35.31M24.03M24.65M
Free Cash Flow+14.15M20.08M17.01M22.53M19.43M30.89M45.4M30.52M-1.76M22.42M
FCF Growth %0.85%0.42%-0.15%0.32%-0.14%0.59%0.47%-0.33%-1.06%13.74%
FCF Margin %----------
FCF per Share7.1110.488.9711.8810.2516.2923.8916.08-0.9311.85

Key Ratios

Metric2015201620172018201920202021202220232024
Combined Ratio86.02%79.69%81.27%82.68%78.3%78.99%74.22%89.38%88.33%84.72%
Medical Cost Ratio52.4%46.13%44.52%41.88%41.59%47.38%45.07%44.4%39.22%43.31%
Return on Equity (ROE)8.95%13.1%15.43%12.37%17.14%20.12%31.21%10.17%8.81%12.35%
Return on Assets (ROA)6.13%8.86%10.76%8.86%12.38%14.42%21.82%7.12%6.47%9.36%
Equity / Assets67.5%67.76%71.48%71.9%72.51%70.84%69.11%70.94%76.1%75.48%
Book Value / Share71.7581.0193.8492.59100.93105.71120.57126.98132.89133.07
Debt / Equity----0.02x0.02x0.02x0.03x0.03x0.03x
Revenue Growth3.31%8.87%16.71%-3.32%17.43%28.83%39.38%-13.99%-20.69%14.93%

Revenue by Segment

2015201620172018201920202021202220232024
Net Premiums Written---138.13M145.84M205.42M273.88M248.63M171.16M204.26M
Net Premiums Written Growth----5.59%40.85%33.33%-9.22%-31.16%19.34%
Escrow, Title-Related And Other Fees---7.1M7.47M8.32M13.68M21.72M17.11M17.95M
Escrow, Title-Related And Other Fees Growth----5.33%11.33%64.38%58.80%-21.23%4.94%
Investment Related Revenue---3.49M19.59M13.35M27.5M-2.63M16.25M17.94M
Investment Related Revenue Growth----461.85%-31.82%105.92%-109.55%719.00%10.37%
Non-Title Services---7.08M9.92M8.69M9.67M14.52M19.24M17.19M
Non-Title Services Growth----40.10%-12.39%11.20%50.24%32.45%-10.63%
Other Resources, Miscellaneous---470K678K623K4.77M1.14M991K947K
Other Resources, Miscellaneous Growth----44.26%-8.11%665.97%-76.09%-13.15%-4.44%
Operatings122.21M133.38M160.26M-------
Operatings Growth-9.15%20.15%-------
Others----------
Others Growth----------
Intersegment Eliminations-1.96M-2.39M-6.79M-------
Intersegment Eliminations Growth--22.05%-184.53%-------

Frequently Asked Questions

Valuation & Price

Investors Title Company (ITIC) has a price-to-earnings (P/E) ratio of 15.5x. This is roughly in line with market averages.

Growth & Financials

Investors Title Company (ITIC) grew revenue by 14.9% over the past year. This is steady growth.

Yes, Investors Title Company (ITIC) is profitable, generating $23.8M in net income for fiscal year 2024 (12.0% net margin).

Dividend & Returns

Yes, Investors Title Company (ITIC) pays a dividend with a yield of 6.19%. This makes it attractive for income-focused investors.

Investors Title Company (ITIC) has a return on equity (ROE) of 12.3%. This is reasonable for most industries.

Industry Metrics

Investors Title Company (ITIC) has a combined ratio of 84.7%. A ratio below 100% indicates underwriting profitability.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.